Role of cyclinD1 and CDK4 in the carcinogenesis induced by silica

Ke-Xia Yan1, Bing-Ci Liu, Xiang-Lin Shi

  • 1National Institute of Occupational Health and Poisons Control, Chinese Center for Disease Control and Prevention, 29 Nan Wei Road, Beijing 100050, China.

Abstract

Insights

Silica-induced malignant transformation of human lung fibroblasts involves cyclin D1 and CDK4 overexpression. Suppressing these genes with antisense RNA halts cell cycle progression and reduces proliferation, indicating their critical role in maintaining the transformed cell phenotype.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Silica exposure is linked to lung diseases and potential malignant transformation.
  • Understanding the molecular mechanisms of silica-induced cell transformation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of cyclin D1 and CDK4 in silica-induced malignant transformation of human fetal lung diploid fibroblast cells (2BS).

Main Methods:

  • Construction and transfection of recombination vectors expressing sense and antisense cyclin D1 and CDK4 into silica-transformed 2BS cells.
  • Utilized pXJ41-neo as a control vector.
  • Assessed gene expression, cell cycle distribution, proliferation rates, and anchorage-independent growth.

Main Results:

  • Cyclin D1 and CDK4 were overexpressed during silica-induced malignant transformation.
  • Antisense RNA effectively suppressed cyclin D1 and CDK4 expression.
  • Suppression led to G1 phase cell cycle arrest, reduced proliferation rates, and decreased anchorage-independent growth.
  • Transfection with antisense cyclin D1 and CDK4 significantly inhibited the growth of transformed cells.

Conclusions:

  • Cyclin D1 and CDK4 are critical regulators in the malignant transformation process induced by silica.
  • These proteins play a significant role in maintaining the transformed phenotype of cancer cells.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...